Rvidence-based advances in transfusion practice in neonatal intensive care units

Neonatology

Volumn 106, Issue 3, 2014, Pages 245-253

  Christensen, Robert D ^a   Carroll, Patrick D ^a   Josephson, Cassandra D ^b,c  

^a INTERMOUNTAIN HEALTHCARE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

Author keywords

Erythrocytes; Fresh frozen plasma; Platelets; Transfusion

Indexed keywords

ANTIANEMIC AGENT; ERYTHROPOIETIN; FRESH FROZEN PLASMA; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN;

BLOOD CLOTTING TEST; BLOOD TRANSFUSION; ERYTHROCYTE TRANSFUSION; EVIDENCE BASED MEDICINE; EXTRACORPOREAL OXYGENATION; HUMAN; LOW BIRTH WEIGHT; META ANALYSIS (TOPIC); NEWBORN INTENSIVE CARE; PHLEBOTOMY; PLASMA TRANSFUSION; PREMATURE LABOR; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTE VOLUME; UMBILICAL CORD CLAMP; UNITED STATES; VERY LOW BIRTH WEIGHT; BLOOD; EVIDENCE BASED PRACTICE; INFANT, NEWBORN, DISEASES; NEWBORN; PREMATURITY; PROFESSIONAL PRACTICE; STANDARDS; TRANSFUSION MEDICINE; TRENDS;

BLOOD TRANSFUSION; EVIDENCE-BASED PRACTICE; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INFANT, PREMATURE; INTENSIVE CARE UNITS, NEONATAL; PLATELET TRANSFUSION; PROFESSIONAL PRACTICE; TRANSFUSION MEDICINE; UNITED STATES;

EID: 84908607722     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000365135     Document Type: Review

References (80)

1. Josephson CD, Glynn SA, Kleinman SH, Blajchman MA; State-of-the Science Symposium Transfusion Medicine Committee: A multidisciplinary 'think tank': The top 10 clinical trial opportunities in transfusion medicine from the National Heart, Lung, and Blood Institute-sponsored 2009 state-of-the-science symposium. Transfusion 2011; 51: 828-841.
2. Kelly AM, Williamson LM: Neonatal transfusion. Early Hum Dev 2013; 89: 855-860.
3. Venkatesh V, Curley AE, Clarke P, Watts T, Stanworth SJ: Do we know when to treat neonatal thrombocytopaenia? Arch Dis Child Fetal Neonatal Ed 2013; 98:F380-F382.
4. Venkatesh V, Khan R, Curley A, New H, Stanworth S: How we decide when a neonate needs a transfusion. Br J Haematol 2013; 160: 421-433.
5. Sallmon H, Sola-Visner M: Clinical and research issues in neonatal anemia and thrombocytopenia. Curr Opin Pediatr 2012; 24: 16-22.
6. Strauss RG: Anaemia of prematurity: pathophysiology and treatment. Blood Rev 2010; 24: 221-225.
7. Strauss RG: Platelet transfusions in neonates: questions and answers. Expert Rev Hematol 2010; 3: 7-9.
8. Sawaya GF, Guirguis-Blake J, LeFevre M, Harris R, Petitti D; U.S. Preventive Services Task Force: Update on the methods of the U.S. Preventive Services Task Force: estimating certainty and magnitude of net benefit. Ann Intern Med 2007; 147: 871-875.
9. Downey CL, Bewley S: Historical perspectives on umbilical cord clamping and neonatal transition. J R Soc Med 2012; 105: 325-329.
10. Darwin E: Zoonomia. Dublin, Dugdale, 1801, vol 3.
11. Yao AC, Lind J: Effect of gravity on placental transfusion. Lancet 1969; 2: 505-508.
12. Yao AC, Lind J, Tiisala R, Michelsson K: Placental transfusion in the premature infant with observation on clinical course and outcome. Acta Paediatr Scand 1969; 58: 561-566.
13. Rabe H, Diaz-Rossello JL, Duley L, Dowswell T: Effect of timing of umbilical cord clamping and other strategies to influence placental transfusion at preterm birth on maternal and infant outcomes. Cochrane Database Syst Rev 2012; 8:CD003248.
14. Sisson TR, Knutson S, Kendall N: The blood volume of infants. IV. Infants born by cesarean section. Am J Obstet Gynecol 1973; 117: 351-357.
15. Hosono S, Mugishima H, Fujita H, Hosono A, Minato M, Okada T, Takahashi S, Harada K: Umbilical cord milking reduces the need for red cell transfusions and improves neonatal adaptation in infants born at less than 29 weeks' gestation: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 2008; 93:F14-F19.
16. Hosono S, Mugishima H, Fujita H, Hosono A, Okada T, Takahashi S, Masaoka N, Yamamoto T: Blood pressure and urine output during the first 120 h of life in infants born at less than 29 weeks gestation related to umbilical cord milking. Arch Dis Child Fetal Neonatal Ed 2009; 94:F328-F331.
17. Freise KJ, Widness JA, Veng-Pedersen P: Erythropoietic response to endogenous erythropoietin in premature very low birth weight infants. J Pharmacol Exp Ther 2010; 332: 229-237.
18. Carroll PD, Nankervis CA, Iams J, Kelleher K: Umbilical cord blood as a replacement source for admission complete blood count in premature infants. J Perinatol 2012; 32: 97-102.
19. Hansen A, Forbes P, Buck R: Potential substitution of cord blood for infant blood in the neonatal sepsis evaluation. Biol Neonate 2005; 88: 12-18.
20. Herson VC, Block C, McLaughlin JC, Tetreault J, Eisenfeld LI, Krause PJ: Placental blood sampling: an aid to the diagnosis of neonatal sepsis. J Perinatol 1998; 18: 135-137.
21. Polin JI, Knox I, Baumgart S, Campman E, Mennuti MT, Polin RA: Use of umbilical cord blood culture for detection of neonatal bacteremia. Obstet Gynecol 1981; 57: 233-237.
22. Christensen RD, Lambert DK, Baer VL, Montgomery DP, Barney CK, Coulter DM, Ilstrup S, Bennett ST: Postponing or eliminating red blood cell transfusions of very low birth weight neonates by obtaining all baseline laboratory blood tests from otherwise discarded fetal blood in the placenta. Transfusion 2011; 51: 253-258.
23. Bekeris LG, Tworek JA, Walsh MK, Valenstein PN: Trends in blood culture contamination: a College of American Pathologists QTracks study of 356 institutions. Arch Pathol Lab Med 2005; 129: 1222-1225.
24. Gonsalves WI, Cornish N, Moore M, Chen A, Varman M: Effects of volume and site of blood draw on blood culture results. J Clin Microbiol 2009; 47: 3482-3485.
25. Connell TG, Rele M, Cowley D, Buttery JP, Curtis N: How reliable is a negative blood culture result? Volume of blood submitted for culture in routine practice in a children's hospital. Pediatrics 2007; 119: 891-896.
26. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia: Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004; 114: 297-316.
27. Judd WJ: Practice guidelines for prenatal and perinatal immunohematology, revisited. Transfusion 2001; 41: 1445-1452.
28. Baer VL, Lambert DK, Carroll PD, Gerday E, Christensen RD: Using umbilical cord blood for the initial blood tests of VLBW neonates results in higher hemoglobin and fewer RBC transfusions. J Perinatol 2013; 33: 363-365.
29. Ringer SA, Richardson DK, Sacher RA, Keszler M, Churchill WH: Variations in transfusion practice in neonatal intensive care. Pediatrics 1998; 101: 194-200.
30. Becquet O, Guyot D, Kuo P, et al: Respective effects of phlebotomy losses and erythropoietin treatment on the need for blood transfusion in very premature infants. BMC Pediatr 2013; 13: 176.
31. Rosebraugh MR, Widness JA, Nalbant D, Veng-Pedersen P: A mathematical modeling approach to quantify the role of phlebotomy losses and need for transfusions in neonatal anemia. Transfusion 2013; 53: 1353-1360.
32. Kling PJ, Sullivan TM, Leftwich ME, Roe DJ: Score for neonatal acute physiology and phlebotomy blood loss predict erythrocyte transfusions in premature infants. Arch Pediatr Adolesc Med 1997; 151: 27-31.
33. Valieva OA, Strandjord TP, Mayock DE, Juul SE: Effects of transfusions in extremely low birth weight infants: a retrospective study. J Pediatr 2009; 155: 331-337.
34. Madan A, Kumar R, Adams MM, Benitz WE, Geaghan SM, Widness JA: Reduction in red blood cell transfusions using a bedside analyzer in extremely low birth weight infants. J Perinatol 2005; 25: 21-25.
35. Widness JA, Madan A, Grindeanu LA, Zimmerman MB, Wong DK, Stevenson DK: Reduction in red blood cell transfusions among preterm infants: results of a randomized trial with an in-line blood gas and chemistry monitor. Pediatrics 2005; 115: 1299-1306.
36. Barie PS: Phlebotomy in the intensive care unit: strategies for blood conservation. Crit Care 2004; 8(suppl 2):S34-S36.
37. Pabla L, Watkins E, Doughty HA: A study of blood loss from phlebotomy in renal medical inpatients. Transfus Med 2009; 19: 309-314.
38. Ohlsson A, Aher SM: Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2012; 9: CD004863.
39. Aher SM, Ohlsson A: Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2014; 23; 4: CD004868.
40. Aher SM, Ohlsson A: Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2012; 10:CD004865.
41. Donato H, Vain N, Rendo P, Vivas N, Prudent L, Larguia M, Digregorio J, Vecchiarelli C, Valverde R, Garcia C, Subotovsky P, Solana C, Gorenstein A: Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo- controlled, multicenter trial. Pediatrics 2000; 105: 1066-1072.
42. Maier RF, Obladen M, Muller-Hansen I, Kattner E, Merz U, Arlettaz R, Groneck P, Hammer H, Kossel H, Verellen G, Stock GJ, Lacaze-Masmonteil T, Claris O, Wagner M, Matis J, Gilberg F; European Multicenter Erythropoietin Beta Study Group: Early treatment with erythropoietin beta amelioratesanemia and reduces transfusion requirements in infants with birth weights below 1000 g. J Pediatr 2002; 141: 8-15.
43. Ohls RK, Christensen RD, Kamath-Rayne BD, Rosenberg A, Wiedmeier SE, Roohi M, Lacy CB, Lambert DK, Burnett JJ, Pruckler B, Schrader R, Lowe JR: A randomized, masked, placebocontrolled study of darbepoetin alfa in preterm infants. Pediatrics 2013; 132:e119-e127.
44. Ohls RK, Kamath-Rayne BD, Christensen RD, Wiedmeier SE, Rosenberg A, et al: Cognitive outcomes of preterm infants randomized to darbepoetin, erythropoietin, or placebo. Pediatrics 2014; 133: 1023-1030.
45. Egrie JC, Browne JK: Development and characterization of novel erythropoiesis stimulating protein (NESP). Br J Cancer 2001; 84 (suppl 1):3-10.
46. Bierer R, Peceny MC, Hartenberger CH, Ohls RK: Erythropoietin concentrations and neurodevelopmental outcome in preterm infants. Pediatrics 2006; 118:e635-e640.
47. McAdams RM, McPherson RJ, Mayock DE, Juul SE: Outcomes of extremely low birth weight infants given early high-dose erythropoietin. J Perinatol 2013; 33: 226-230.
48. Neubauer AP, Voss W, Wachtendorf M, Jungmann T: Erythropoietin improves neurodevelopmental outcome of extremely preterm infants. Ann Neurol 2010; 67: 657-666.
49. Brown MS, Eichorst D, Lala-Black B, Gonzalez R: Higher cumulative doses of erythropoietin and developmental outcomes in preterm infants. Pediatrics 2009; 124:e681-e687.
50. Carr R, Kelly AM, Williamson LM: Neonatal thrombocytopenia and platelet transfusion - A UK perspective. Neonatology 2015;107:DOI: 10.1159/00365163.
51. Galel SA, Fontaine MJ, Viele MK, Gonzalez L, Goodnough LT: Transfusion medicine; in Greer JP, Arber DA, Glader B, List AF, Means RT Jr, Paraskevas F, Rodgers GM (eds): Wintrobe's Clinical Hematology, ed 13. Philadelphia, Lippincott, Williams & Wilkins, 2014, pp 556-557.
52. Sola-Visner MC: Platelets in the neonatal period: developmental differences in platelet production, function, and hemostasis and the potential impact of therapies. Hematology Am Soc Hematol Educ Program 2012; 2012: 506-511.
53. Christensen RD: Platelet transfusion in the neonatal intensive care unit: benefits, risks, alternatives. Neonatology 2011; 100: 311-318.
54. Cremer M, Sola-Visner M, Roll S, Josephson CD, Yilmaz Z, Buhrer C, Dame C: Platelet transfusions in neonates: practices in the United States vary significantly from those in Austria, Germany, and Switzerland. Transfusion 2011; 51: 2634-2641.
55. Josephson CD, Su LL, Christensen RD, Hillyer CD, Castillejo MI, Emory MR, Lin Y, Hume H, Easley K, Poterjoy B, Sola-Visner M: Platelet transfusion practices among neonatologists in the United States and Canada: results of a survey. Pediatrics 2009; 123: 278-285.
56. Stanworth SJ, Clarke P, Watts T, Ballard S, Choo L, Morris T, Murphy MF, Roberts I; Platelets and Neonatal Transfusion Study Group: Prospective, observational study of outcomes in neonates with severe thrombocytopenia. Pediatrics 2009; 124:e826-e834.
57. Venkatesh V, Khan R, Curley A, New H, Stanworth S: How we decide when a neonate needs a transfusion. Br J Haematol 2013; 160: 421-433.
58. Christensen RD, Paul DA, Sola-Visner MC, Baer VL: Improving platelet transfusion practices in the neonatal intensive care unit. Transfusion 2008; 48: 2281-2284.
59. Gerday E, Baer VL, Lambert DK, Paul DA, Sola-Visner MC, Pysher TJ, Christensen RD: Testing platelet mass versus platelet count to guide platelet transfusions in the neonatal intensive care unit. Transfusion 2009; 49: 2034- 2039.
60. Zisk JL, Mackley A, Clearly G, Chang E, Christensen RD, Paul DA: Transfusing neonates based on platelet count vs. platelet mass: a randomized feasibility-pilot study. Platelets 2013, Epub ahead of print.
61. von Lindern JS, van den Bruele T, Lopriore E, Walther FJ: Thrombocytopenia in neonates and the risk of intraventricular hemorrhage: a retrospective cohort study. BMC Pediatr 2011; 11: 16.
62. von Lindern JS, Hulzebos CV, Bos AF, Brand A, Walther FJ, Lopriore E: Thrombocytopaenia and intraventricular haemorrhage in very premature infants: a tale of two cities. Arch Dis Child Fetal Neonatal Ed 2012; 97:F348- F352.
63. Ferrer-Marin F, Stanworth S, Josephson C, Sola-Visner M: Distinct differences in platelet production and function between neonates and adults: implications for platelet transfusion practice. Transfusion 2013; 53: 2814- 2821.
64. Andrew M, Vegh P, Caco C, Kirpalani H, Jefferies A, Ohlsson A, Watts J, Saigal S, Milner R, Wang E: A randomized, controlled trial of platelet transfusions in thrombocytopenic premature infants. J Pediatr 1993; 123: 285- 291.
65. Neary E, Okafor I, Al-Awaysheh F, Kirkham C, Sheehan K, Mooney C, Foran A, Corcoran JD, Ni-Ainle F, Cotter M, McCallion N: Laboratory coagulation parameters in extremely premature infants born earlier than 27 gestational weeks upon admission to a neonatal intensive care unit. Neonatology 2013; 104: 222- 227.
66. Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, Castle V, Powers P: Development of the human coagulation system in the healthy premature infant. Blood 1988; 72:. 1651-1657.
67. Christensen RD, Baer VL, Lambert DK, Henry E, Ilstrup SJ, Bennett ST: Reference intervals for common coagulation tests of preterm infants. Transfusion 2014; 54: 627-632.
68. Catford K, Reddy C, Clarke P: Routine neonatal coagulation testing increases use of freshfrozen plasma. Transfusion 2014; 54: 1444- 1445.
69. MacLennan S, Williamson LM: Risks of fresh frozen plasma and platelets. J Trauma 60:S46- S50.
70. Chaudhary R, Clarke P: Current transfusion practices for platelets and fresh, frozen plasma in UK tertiary level neonatal units. Acta Paediatr 2008; 97: 135.
71. Motta M, Del Vecchio A, Radicioni M: Clinical use of fresh-frozen plasma and cryoprecipitate in neonatal intensive care unit. J Matern Fetal Neonatal Med 2011; 24 (suppl 1):129-131.
72. Motta M, Testa M, Tripodi G, Radicioni M: Changes in neonatal transfusion practice after dissemination of neonatal recommendations. Pediatrics 2010; 125:e810-e817.
73. Emmerson AJ: Role of erythropoietin in the newborn. Arch Dis Child 1993;69(3 Spec No):273-275.
74. Messer J, Haddad J, Donato L, Astruc D, Matis J: Early treatment of premature infants with recombinant human erythropoietin. Pediatrics 1993;92:519-523.
75. Maier RF, Obladen M, Scigalla P, Linderkamp O, Duc G, Hieronimi G, Halliday HL, Versmold HT, Moriette G, Jorch G, Verellen G, Semmekrot BA, Grauel EL, Holland BM, Wardrop C for the European Multicentre Erythropoietin Study Group: The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-lowbirth- weight infants. European Multicentre Erythropoietin Study Group. N Engl J Med 1994;330:1173-1178.
76. Ohls RK, Ehrenkranz RA, Wright LL, Lemons JA, Korones SB, Stoll BJ, Stark AR, Shankaran S, Donovan EF, Close NC, Das A: Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: a multicenter, randomized, controlled trial. Pediatrics 2001;108:934-942.
77. Haiden N, Schwindt J, Cardona F, Berger A, Klebermass K, Wald M, Kohlhauser-Vollmuth C, Jilma B, Pollak A: Effects of a combined therapy of erythropoietin, iron, folate, and vitamin B12 on the transfusion requirements of extremely low birth weight infants. Pediatrics 2006;118:2004-2013.
78. Birenbaum HJ, Pane MA, Helou SM, Starr KP: Comparison of a restricted transfusion schedule with erythropoietin therapy versus a restricted transfusion schedule alone in very low birth weight premature infants. South Med J 2006;99:1059-1062.
79. Khatami SF, Mamouri G, Torkaman M: Effects of early human recombinant erythropoietin therapy on the transfusion in healthy preterm infants. Indian J Pediatr 2008;75:1227- 1230.
80. Tempera A, Stival E, Piastra M, De Luca D, Ottaviano C, Tramontozzi P, Marconi M, Cafforio C, Marcozzi P, Rossi N, Buffone E: Early erythropoietin influences both transfusion and ventilation need in very low birth weight infants. J Matern Fetal Neonatal Med 2011;24:1060-1064.